Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism MTAP inhibitors(Methylthioadenosine phosphorylase inhibitors), PRMT5 inhibitors(Protein arginine methyltransferase 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Neoplasms | Preclinical | US | 25 Jun 2024 | |
Solid tumor | Preclinical | US | 25 Jun 2024 | |
Brain metastases | Discovery | US | 28 Dec 2023 |